Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Eli

Explore full profile

Enables women to take control of their health across their reproductive lives, by providing them with their daily hormone profile

Montreal, CanadaFounded 2019Health Tech & Medtech
Valuation $0–100M Latest valuation · 2025
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Eli and the history behind them.

About Eli

Eli.health is a pioneering startup focused on women's health, specifically in the realm of hormone monitoring and reproductive health. The company has developed a unique, patent-pending point-of-care device that allows women to measure their hormone levels at home using a simple saliva sample. This device provides a non-invasive, hormone-free alternative to traditional contraceptive methods, addressing a significant unmet need in the market.

Read full description

Eli.health primarily serves women who are looking for reliable and convenient ways to monitor their reproductive health. This includes women who are trying to conceive, those who want to avoid pregnancy, and those who are navigating menopause. The company's technology is particularly beneficial for women in their early 30s, a demographic that is increasingly experiencing fertility challenges.

The market Eli.health operates in is the broader women's health and fertility sector, which is seeing growing demand for innovative, user-friendly solutions. The company's business model revolves around a subscription service. Users purchase the device and then subscribe to receive proprietary consumables that are necessary for the hormone monitoring process. This recurring revenue model ensures a steady income stream for the company.

Eli.health also offers an app that provides personalized insights based on the hormone data collected by the device. This app uses advanced learning algorithms to interpret hormone variations, giving users precise information about their fertile days and overall reproductive health. This data is invaluable for couples trying to conceive, as it significantly increases their chances of success.

In summary, Eli.health is revolutionizing women's reproductive health by offering a convenient, non-invasive, and highly effective hormone monitoring solution. The company's innovative approach not only meets a critical need but also provides a sustainable business model through its subscription service.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Montreal, Canada
Employees
31
Open positions
1
Dealroom signal
88.6/100
Industry
Health, Wellness Beauty
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Fertility, Women's Health, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology
Deep Tech, Mobile app
Business model
SaaS
Client focus
b2c

Latest news

Press, funding announcements and product moves mentioning Eli.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jun 2025 $12M $48M BDC Capital
SEEDEquity / VC Apr 2023 $3.7M $15M Real Ventures · Panache Ventures · TELUS Pollinator Fund for Good · MEDTEQ+
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Eli website traffic

Latest recorded traffic for Eli is 46K monthly website visits, down 27% over the last three months. Eli's team grew 24% over the past year.

Latest monthly visits46K 3-month web change-27% 1-year team growth+24%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed16 investors entered at this stage

  • Centech
  • Techstars
  • MEDTEQ
  • Real Ventures
  • 2048 Ventures
  • Steven Arless
  • Vectr Ventures
  • Panache Ventures
  • Muse Capital
  • TELUS Pollinator Fund for Good
  • MEDTEQ+
  • RHIA Ventures
  • Cake Ventures
  • Leva Capital
  • Garage Capital
  • Parth Khanna

Series A1 investor entered at this stage

Other known investors3 additional known investors

  • FounderFuel
  • Québec Tech
  • Riyadh Techstars Accelerator
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇨🇦 Canada60%
🇺🇸 United States28%
🇮🇳 India4%
🇷🇴 Romania4%
🇮🇱 Israel4%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Eli on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Eli’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.